$125 | Single User
$250 | Site License
$375 | Enterprise License

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review [Report Updated: 17-10-2017]

Published by Global Data: 17 Oct 2017 | 139810 | In Stock

Introduction

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NeuroSearch A/S (NeuroSearch) focuses on the development of novel pharmaceutical agents for the treatment of various disorders of central nervous system (CNS) through license agreements with other life science companies. The company divested all rights of Huntexil for the treatment of patients with Huntington's disease to Teva Pharmaceuticals. It also sold all the preclinical and clinical assets, and further development of NS2330 (tesofensine) and NS2359 as well as of any potential drugs based on NS2330 or NS2359 to Saniona A/S and Saniona AB (Saniona). NeuroSearch is entitled to receive a one-time cash payment from Saniona and milestone payments from Teva. NeuroSearch is headquartered in Hallerup, Denmark.

NeuroSearch AS Key Recent Developments

Aug 31,2017: NeuroSearch – H1 report 2017

Feb 24,2017: NeuroSearch releasing Annual Report 2016

Aug 31,2016: NeuroSearch: H1 report 2016

Mar 04,2016: NeuroSearch releasing Annual Report 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review [Report Updated: 17-10-2017]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Section 1 - About the Company 5

    NeuroSearch A/S - Key Facts 5

    NeuroSearch A/S - Key Employees 6

    NeuroSearch A/S - Key Employee Biographies 7

    NeuroSearch A/S - Major Products and Services 8

    NeuroSearch A/S - History 9

    NeuroSearch A/S - Locations And Subsidiaries 13

    Head Office 13

    Section 2 – Company Analysis 14

    NeuroSearch A/S - Business Description 14

    NeuroSearch A/S - Corporate Strategy 15

    NeuroSearch A/S - SWOT Analysis 16

    SWOT Analysis - Overview 16

    NeuroSearch A/S - Strengths 16

    NeuroSearch A/S - Weaknesses 17

    NeuroSearch A/S - Opportunities 18

    NeuroSearch A/S - Threats 19

    NeuroSearch A/S - Key Competitors 20

    Section 3 – Company Financial Ratios 21

    Financial Ratios - Capital Market Ratios 21

    Financial Ratios - Annual Ratios 22

    Performance Chart 24

    Financial Performance 24

    Financial Ratios - Interim Ratios 25

    Financial Ratios - Ratio Charts 26

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 27

    NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

    NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

    NeuroSearch A/S, Recent Deals Summary 29

    Section 5 – Company’s Recent Developments 30

    Aug 31, 2017: NeuroSearch – H1 report 2017 30

    Feb 24, 2017: NeuroSearch releasing Annual Report 2016 32

    Aug 31, 2016: NeuroSearch: H1 report 2016 34

    Mar 04, 2016: NeuroSearch releasing Annual Report 2015 36

    Section 6 – Appendix 37

    Methodology 37

    Ratio Definitions 37

    About GlobalData 41

    Contact Us 41

    Disclaimer 41

List Of Tables
in NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review [Report Updated: 17-10-2017]

List of Tables

NeuroSearch A/S, Key Facts 5

NeuroSearch A/S, Key Employees 6

NeuroSearch A/S, Key Employee Biographies 7

NeuroSearch A/S, Major Products and Services 8

NeuroSearch A/S, History 9

NeuroSearch A/S, Key Competitors 20

NeuroSearch A/S, Ratios based on current share price 21

NeuroSearch A/S, Annual Ratios 22

NeuroSearch A/S, Annual Ratios (Cont...1) 23

NeuroSearch A/S, Interim Ratios 25

NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

NeuroSearch A/S, Recent Deals Summary 29

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

List Of Figures, Charts and Diagrams
in NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review [Report Updated: 17-10-2017]

List of Figures

NeuroSearch A/S, Performance Chart (2012 - 2016) 24

NeuroSearch A/S, Ratio Charts 26

NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

NeuroSearch A/S, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 28

Additional Details

Publisher

Global Data

Publisher Information

Reference

139810 |

Number of Pages

41

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) focuses on the development of novel pharmaceutical agents for t...
19 Feb 2018 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) focuses on the development of novel pharmaceutical agents for t...
28 Nov 2017 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) develops novel pharmaceutical agents for the treatment of vario...
27 Jul 2017 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) develops novel pharmaceutical agents for the treatment of vario...
17 May 2017 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) develops novel pharmaceutical agents for the treatment of vario...
20 Mar 2017 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) develops novel pharmaceutical agents for the treatment of vario...
25 Nov 2016 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) is a biopharmaceutical company that develops novel pharmaceutic...
24 Aug 2016 by Global Data USD $250 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) is a biopharmaceutical company that develops novel pharmaceutic...
15 Apr 2016 by Global Data USD $250 More Info
NeuroSearch A/S – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeuroSearch A/S (NeuroSearch) is a biopharmaceutical company that develops novel pharmaceutic...
08 Mar 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review [Report Updated: 17-10-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data